Clarithromycin

Revision as of 19:46, 8 January 2014 by Gerald Chi (talk | contribs) (Changed protection level for "Clarithromycin" ([Edit=Allow only autoconfirmed users] (expires 19:46, 22 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 19:46, 22 January 2014 (UTC))))
Jump to navigation Jump to search

Synonyms / Brand Names: CLA, Clarithromycine, Clathromycin, Biaxin, Biaxin XL, Klacid, Klaricid, Macladin, Naxy, Veclam, Zeclar

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

BIAXIN Filmtab (clarithromycin tablets, USP) and BIAXIN Granules (clarithromycin for oral suspension, USP) may be given with or without food. BIAXIN XL Filmtab (clarithromycin extended-release tablets) should be taken with food. BIAXIN XL tablets should be swallowed whole and not chewed, broken or crushed.
Adult dosage guidelines
For pharyngitis/tonsillitis due to S. pyogenes:

  • 250 mg (q12h) of BIAXIN tablets should be given for a duration of 10 days.

For acute maxillary sinusitis due to H. influenzae, M. catarrhalis, and/or S. pneumonia:

  • 500 mg (q12h) of BIAXIN tablets should be given for a duration of 14 days or
  • 2 x 500 mg (q24h) of BIAXIN XL tablets should be given for a duration of 14 days.

For acute exacerbation of chronic bronchitis due to H. influenzae, M catarrhalis, and/or S. pneumoniae:

  • 500 mg (q12h) of BIAXIN tablets should be given for a duration of 7-14 days or
  • 2 x 500 mg (q24h) of BIAXIN XL tablets should be given for a duration of 7 days.

For acute exacerbation of chronic bronchitis due to H. parainfluenzae:

  • 500 mg (q12h) of BIAXIN tablets should be given for a duration of 7 days or
  • 2 x 500 mg (q24h) of BIAXIN XL tablets should be given for a duration of 7 days.

For community-acquired pneumonia due to H. influenzae:

  • 250 mg (q12h) of BIAXIN tablets should be given for a duration of 7 days or
  • 2 x 500 mg (q24h) of BIAXIN XL tablets should be given for a duration of 7 days.

For community-acquired pneumonia due to H. parainfluenzae and/or M. catarrhalis:

  • 2 x 500 mg (q24h) of BIAXIN XL tablets should be given for a duration of 7 days.

For community-acquired pneumonia due to S. pneumoniae, C. pneumoniae, and/or M. pneumoniae:

  • 250 mg (q12h) of BIAXIN tablets should be given for a duration of 7-14 days or
  • 2 x 500 mg (q24h) of BIAXIN XL tablets should be given for a duration of 7 days.

For uncomplicated skin and skin structure due to S. aureus and/or S.pyogenes:

  • 250 mg (q12h) of BIAXIN tablets should be given for a duration of 7 days.

For further dosage and administration instructions see Instructions for Administration.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Clarithromycin

Return to top

Publication Resources

Most Recent Articles on Clarithromycin

Review Articles on Clarithromycin

Articles on Clarithromycin in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Clarithromycin

Return to top

Trial Resources

Ongoing Trials with Clarithromycin at Clinical Trials.gov

Trial Results with Clarithromycin

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Clarithromycin

Cochrane Collaboration on Clarithromycin

Cost Effectiveness of Clarithromycin

Return to top

Media Resources

Powerpoint Slides on Clarithromycin

Images of Clarithromycin

Podcasts & MP3s on Clarithromycin

Videos on Clarithromycin

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Clarithromycin

Discussion Groups on Clarithromycin

Patient Handouts on Clarithromycin

Blogs on Clarithromycin

Clarithromycin in the News

Clarithromycin in the Marketplace

Return to top

International Resources

Clarithromycin en Español

Return to top


Adapted from the FDA Package Insert.